$Nanoviricides (NNVC.US)$ Announced that its pan-coronavirus...

Announced that its pan-coronavirus novel Coronavirus-19 candidate NV-COV-2 has been found to be effective against SARS-COV-2 in standard cell culture pseudovirus tests, demonstrating broad-spectrum pan-coronavirus activity.

This implies that NV-COV-2 should remain active despite the constant mutation of SARS-COV-2.